Mitochondrial Diseases - 27 Studies Found
Terminated |
: RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease : Mitochondrial Diseases : 2003-05-07 : Drug: RG2133 (2',3',5'-tri-O-acetyluridine) |
Recruiting |
: An Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300) : Primary Mitochondrial Disease : 2017-02-03 |
Active, not recruiting |
: A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study : Primary Mitochondrial Disease : 2016-06-13 :
|
Completed |
: Energy Requirements in Mitochondrial Disease :
: 2013-01-17 |
Completed |
: DINAMITE Study Nutritional State and Effect Diet in Mitochondrial Disease : Mitochondrial Disorders : 2014-10-31 : Behavioral: diet intervention The dietary intervention implies optimizing the diet based on individually |
Completed |
: Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease : Inherited Mitochondrial Disease, Including Leigh Syndrome : 2013-12-17 : Drug: Cysteamine Bitartrate Cysteamine Bitartrate Delayed-release Capsules |
Recruiting |
: GDF-15 as a Biomarker for Mitochondrial Disease :
: 2010-06-02 : Procedure: gastric emptying scan subjects will eat a solid |
Recruiting |
: North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) :
|
Active, not recruiting |
: EPI-743 for Mitochondrial Respiratory Chain Diseases : Mitochondrial Diseases : 2011-06-07 : Drug: EPI-743 EPI-743 is administered as a dose escalation from 50 mg bid to 100 mg tid |